
5Y Capital (formerly Morningside Venture Capital) is a Shanghai-based venture capital firm founded in 2008. It invests across technology, life sciences, and consumer innovation sectors, managing dual-currency (USD and RMB) funds backed by sovereign wealth funds, endowments, and family offices.
Deal activity increased 100% year-over-year (4 deals in the last 12 months). Average disclosed round size is $90.8M (across 46 rounds with reported amounts).
Portfolio
46
Fund Size
$2B
Top Stage
Series A
Last 12 Mo
5
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
59 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| SSyneron Bio | Series B | $150M | Mar 2026 |
| DDify | Series A | $30M | Mar 2026 |
| Series B | $270M | Jan 2026 | |
| Unknown | $200M | Jan 2026 | |
| SSyneron Bio | Series A | — | Dec 2025 |
| MMinghui Pharmaceutical | Ipo | $131M | Aug 2025 |
| Series B | $50M | Nov 2024 | |
| RReviR Therapeutics | Series A | $30M | Jul 2024 |
| RRevir | Series A | $30M | Jul 2024 |
| Seed | $9M | Jan 2024 | |
| BBotinkit | Series A | $13M | Jul 2023 |
| Seed | $25M | Jun 2023 | |
| Unknown | $40M | Nov 2022 | |
| Series A | — | Oct 2022 | |
| Series B | $100M | Jun 2022 | |
| VVisionNav Robotics | Series C | $76M | Apr 2022 |
| RRevir | Seed | $20M | Jan 2022 |
| Unknown | $60M | Jan 2022 | |
| Unknown | $138.4M | Jan 2022 | |
| TTroph | Unknown | — | Dec 2021 |
| RRedesign Science | Seed | — | Dec 2021 |
| HHT Aero | Series A | — | Oct 2021 |
| Series D | $200M | Sep 2021 | |
| Series C | $200M | Sep 2021 | |
| Series B | $100M | Jul 2021 |
Page 1 of 3
Top Co-Investors
GL Ventures10 shared
Source Code Capital8 shared
GGV Capital7 shared
IDG Capital7 shared
HongShan6 shared
Sky9 Capital6 shared
Sequoia China6 shared
Sequoia Capital4 shared
Legend Star4 shared
ZhenFund4 shared
Ant Group4 shared
Toba Capital3 shared
Hillhouse Investment3 shared
Coatue Management LLC3 shared
BAI Capital3 shared
Yunqi Partners3 shared
Yunfeng Capital3 shared
ByteDance3 shared
CDH Investments3 shared
BioTrack Capital3 shared
Last updated: 8 September 2026